Let’s look at the key reasons that are pushing Edgewise Therapeutics Inc (EWTX) to new highs

On Tuesday, Edgewise Therapeutics Inc (NASDAQ: EWTX) was -7.61% drop from the session before settling in for the closing price of $27.07. A 52-week range for EWTX has been $14.90 – $38.12.

When this article was written, the company’s average yearly earnings per share was at 5.75%. With a float of $66.85 million, this company’s outstanding shares have now reached $94.41 million.

The firm has a total of 88 workers. Let’s measure their productivity. In terms of profitability, gross margin is 29.31%, operating margin of -6534.37%, and the pretax margin is -5519.27%.

Edgewise Therapeutics Inc (EWTX) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Edgewise Therapeutics Inc stocks. The insider ownership of Edgewise Therapeutics Inc is 29.40%, while institutional ownership is 76.51%. The most recent insider transaction that took place on Feb 05 ’25, was worth 240,623. In this transaction Chief Scientific Officer of this company sold 8,015 shares at a rate of $30.02, taking the stock ownership to the 14,863 shares. Before that another transaction happened on Feb 06 ’25, when Company’s Chief Scientific Officer sold 1,200 for $30.13, making the entire transaction worth $36,153. This insider now owns 14,863 shares in total.

Edgewise Therapeutics Inc (EWTX) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 5.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.17% during the next five years compared to -68.02% drop over the previous five years of trading.

Edgewise Therapeutics Inc (NASDAQ: EWTX) Trading Performance Indicators

You can see what Edgewise Therapeutics Inc (EWTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 26.35.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.49, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.87 in one year’s time.

Technical Analysis of Edgewise Therapeutics Inc (EWTX)

Analysing the last 5-days average volume posted by the [Edgewise Therapeutics Inc, EWTX], we can find that recorded value of 1.1 million was better than the volume posted last year of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 34.91%. Additionally, its Average True Range was 1.77.

During the past 100 days, Edgewise Therapeutics Inc’s (EWTX) raw stochastic average was set at 12.83%, which indicates a significant increase from 1.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.40% in the past 14 days, which was lower than the 58.51% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $27.72, while its 200-day Moving Average is $24.57. Now, the first resistance to watch is $26.52. This is followed by the second major resistance level at $28.04. The third major resistance level sits at $28.79. If the price goes on to break the first support level at $24.25, it is likely to go to the next support level at $23.50. Now, if the price goes above the second support level, the third support stands at $21.98.

Edgewise Therapeutics Inc (NASDAQ: EWTX) Key Stats

There are 94,689K outstanding shares of the company, which has a market capitalization of 2.37 billion. As of now, sales total 0 K while income totals -100,160 K. Its latest quarter income was 0 K while its last quarter net income were -34,130 K.